Clinical Trials Directory

Trials / Completed

CompletedNCT05837403

The Use of Platelet-rich Plasma in the Treatment of Chronic Anal Fissure

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
460 (actual)
Sponsor
Al-Kindy College of Medicine · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

use of platelet rich plasma had good effect in treating chronic wounds. healing of perianal fissure could be prolonged and associated with pain. injection of platelet rich plasma under fissure base and edges had the advantage of improved fissure healing and reduction of the pain, with minimal side effects.

Detailed description

Thirty milliliters of venous blood were withdrawn into eight syringes with preloaded 0.4 milliliters of anticoagulant (dextrose solution A) in each syringe to achieve concentration of 9:1. The mixture centrifuged for 3000 round per minute for three minutes. After centrifugation separation of supernatant from the red blood cells, using three way-stopcock connector to collect the supernatant of all syringes into four new syringes that preloaded with 1 microgram of Prostaglandin E1 that diluted in normal saline (0.05 milliliters). The four syringes centrifuge at 4000 round per minute for 15 minutes. The supernatant discarded using a three way-stopcock connector. The sediment mixed with vortex mixer (Vortex V-1 plus, BIOSAN).

Conditions

Interventions

TypeNameDescription
PROCEDUREPlatelet rich plasma injectionvenous blood drown from the patient, centrifugation and separation of platelet rich plasma, injection under fissure and edges base.
DRUGNitroglycerin ointmentapplication of the ointment twice daily

Timeline

Start date
2020-10-01
Primary completion
2022-07-30
Completion
2022-09-30
First posted
2023-05-01
Last updated
2023-05-03

Locations

1 site across 1 country: Iraq

Source: ClinicalTrials.gov record NCT05837403. Inclusion in this directory is not an endorsement.